| Primary Aldosteronism | Non-Primary Aldosteronism | |||||||
|---|---|---|---|---|---|---|---|---|
| LVM (g/m2) | IVS (mm) | LVM (g/m2) | IVS (mm) | |||||
| UNa<200 (n=13) | UNa≥200 (n=7) | UNa<200 (n=13) | UNa≥200 (n=7) | UNa<200 (n=5) | UNa≥200 (n=9) | UNa<200 (n=5) | UNa≥200 (n=9) | |
| Baseline | 170.2 | 175.8 | 12.4 | 11.0 | 158.3 | 205.1 | 11.6 | 13.4 |
| Difference between baseline, 3, and 6 month visits after addition of spironolactone | ||||||||
| Baseline to 3 months | −34.8 | −16.0* | −1.5 | 0.1 | −7.0 | −33.2* | −0.4 | −0.7 |
| Baseline to 6 months | −52.0 | −25.0* | −1.4 | 0.5 | −19.8 | −40.5* | 1.2 | −1.4 |
* denotes statistical significance p<0.05